GSKCONS Charts, Analysis and Tips

home > trading-and-exports > gskcons

Technical Analysis

Technical Strength: 4 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 50.9. According to RSI analysis, gskcons is marginally weak. 4.0 GSKCONS RSI Chart
MACD (?) MACD: 38.8 and Signal Line: 60.2. According to MACD analysis, gskcons is marginally weak. 3.0 GSKCONS MACD Chart
Simple Moving Average (?) According to simple moving average analysis, gskcons is facing resistance at 5.29e+03 and support level is at 5175.471. 3.0 GSKCONS Simple Moving Average Chart
Exponential Moving Average (?) Price just got above it's 50-day exponential moving average which is a positive signal. According to exponential moving average analysis, gskcons is facing resistance at 5.29e+03 and support level is at 5234.215. 6.0 GSKCONS Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.485. 5.0 GSKCONS Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 5277.975 and 5207.6529. Resistance level is 5348.2971. 8.0 GSKCONS Fibonacci Retracement Chart
Average True Range (?) ATR: 123 NA GSKCONS Average True Range Chart
Average Directional Index (?) ADX is 31.4 which means GSKCONS is in a trend. NA GSKCONS Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 28, 2017
Open Price 5172.05
High Price 5293.0
Low Price 5160.0
Close Price 5281.95
Absolute Change 98.8
Percentage Change 1.91%
Weekly Change -2.24%
Monthly Change 2.65%
Yearly Change -11.5%
52-week high 6600.0
52-week low 4708.0
Corporate Actions
ExDate Purpose
July 26, 2016 AGM/DIV-RS 70 PER SHARE
July 27, 2015 AGM/DIV-RS 55 PER SHARE
July 28, 2014 AGM/DIV-RS 45 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.349
Confidence in Beta1.78%
Market Capital Rs. 22213.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 163.32
TTM Price-to-Earnings (P/E) Ratio 32.3
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 28 March 2017: Deliverable Quantity:1.02e+04 NA GSKCONS Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 28 March 2017: Daily Volatility:0.2465 NA GSKCONS Annualized Daily Volatility (Spot Price) Chart

Announcements

March 20, 2017 GlaTrading WindowaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Company's Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from March 21, 2017 and shall end 48 hours after public announcement of the Audited / Un-Audited Financial Results for the Financial Year 2016-17.
February 14, 2017 GlaOutcome of Board MeetingaxoSmithKline Consumer Healthcare Limited has informed the Exchange that
See all Announcements

Board Meetings

Date Meeting Date Purpose
March 14, 2017 March 22, 2017 to Others discuss future strategies of the Company.
February 01, 2017 February 13, 2017 To,Results, inter alia, consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2016 with Limited Review by Statutory Auditors.
See all Board Meetings

GSKCONS is part of...

Index Weightage
CNXFMCG NA
CNXMNC NA
CNXCNSMPTN NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 5064 Rs. 5112 Rs. 5197 Rs. 5245 Rs. 5330 Rs. 5378 Rs. 5463